November 09, 2026 at 12:34 PM UTC
Viridian Therapeutics, Inc.\DE issues Regulation FD disclosure
Viridian Therapeutics, Inc.\DE filed an 8-K covering a Regulation FD disclosure and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 09, 2026 at 12:33 PM UTC
Open official source